Annual Net Margin
-5370.24%
NaN%
December 31, 2023
Summary
- As of February 7, 2025, CYCC annual net profit margin is -5370.24%
- CYCC annual net margin is now -201232.58% below its all-time high of 2.67%, reached on January 1, 1994.
Performance
CYCC Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
-19.57 K%
+61.85 K%+75.97%
September 30, 2024
Summary
- As of February 7, 2025, CYCC quarterly net profit margin is -19.57 thousand%, with the most recent change of +61.85 thousand% (+75.97%) on September 30, 2024.
- Over the past year, CYCC quarterly net margin has dropped by -2566.77% (-15.10%).
- CYCC quarterly net margin is now -5065.22% below its all-time high of -378.88%, reached on September 30, 2015.
Performance
CYCC Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
CYCC Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -15.1% |
| 3 y3 years | - | - |
| 5 y5 years | -10.5% | - |
CYCC Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -1239.9% | +76.0% |
| 5 y | 5-year | at high | at low | -1239.9% | +76.0% |
| alltime | all time | <-9999.0% | +91.7% | -5065.2% | +87.2% |
Cyclacel Pharmaceuticals Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -19.57 K%(-76.0%) |
| Jun 2024 | - | -81.42 K%(+701.5%) |
| Mar 2024 | - | -10.16 K%(-40.3%) |
| Dec 2023 | -5370.24%(+10.5%) | -17.00 K%(-54.9%) |
| Sep 2023 | - | -37.70 K%(+2481.1%) |
| Jun 2023 | - | -1460.59%(+8.6%) |
| Dec 2018 | -4858.67%(+247.4%) | -1345.33%(+31.3%) |
| Dec 2016 | -1398.70%(+89.6%) | -1024.91%(-28.7%) |
| Sep 2016 | - | -1437.07%(+7.6%) |
| Jun 2016 | - | -1335.59%(-39.0%) |
| Mar 2016 | - | -2187.77%(+173.0%) |
| Dec 2015 | -737.76%(-34.0%) | -801.43%(+111.5%) |
| Sep 2015 | - | -378.88%(-66.5%) |
| Jun 2015 | - | -1130.74%(+17.9%) |
| Mar 2015 | - | -959.38%(-50.6%) |
| Dec 2014 | -1118.05%(+19.4%) | -1942.92%(+191.0%) |
| Sep 2014 | - | -667.62%(-50.6%) |
| Jun 2014 | - | -1351.69%(+9.9%) |
| Mar 2014 | - | -1229.55%(+3.3%) |
| Dec 2013 | -936.62%(-95.1%) | -1190.30%(-26.5%) |
| Sep 2013 | - | -1619.42%(+11.4%) |
| Mar 2013 | - | -1453.77%(-98.5%) |
| Dec 2012 | -19.11 K%(+33.6%) | -95.28 K%(+1815.7%) |
| Sep 2012 | - | -4973.68%(-63.8%) |
| Jun 2012 | - | -13.76 K%(+550.7%) |
| Jun 2011 | - | -2114.29%(-11.5%) |
| Mar 2011 | - | -2389.58%(-0.2%) |
| Dec 2010 | -14.30 K%(+565.9%) | - |
| Sep 2010 | - | -2394.34%(-27.6%) |
| Jun 2010 | - | -3305.04%(+75.2%) |
| Mar 2010 | - | -1885.98%(-18.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | -2148.19%(-53.4%) | -2319.25%(+70.8%) |
| Sep 2009 | - | -1358.26%(-48.7%) |
| Jun 2009 | - | -2648.50%(+19.3%) |
| Mar 2009 | - | -2220.61%(-29.8%) |
| Dec 2008 | -4605.02%(-75.3%) | -3164.54%(-51.8%) |
| Sep 2008 | - | -6560.22%(+38.2%) |
| Jun 2008 | - | -4746.67%(+34.4%) |
| Mar 2008 | - | -3532.20%(-96.3%) |
| Dec 2007 | -18.65 K%(+146.6%) | -94.62 K%(+640.9%) |
| Sep 2007 | - | -12.77 K%(+10.1%) |
| Jun 2007 | - | -11.60 K%(+23.3%) |
| Mar 2007 | - | -9403.85%(+98.8%) |
| Dec 2006 | -7560.21%(+49.1%) | -4730.77%(-27.7%) |
| Sep 2006 | - | -6544.58%(-66.1%) |
| Jun 2006 | - | -19.28 K%(+156.6%) |
| Mar 2006 | - | -7515.89%(+13.4%) |
| Dec 2005 | -5069.66%(-92.1%) | -6627.14%(+254.1%) |
| Sep 2005 | - | -1871.70%(-73.6%) |
| Jun 2005 | - | -7102.82%(-26.2%) |
| Mar 2005 | - | -9625.00%(-85.1%) |
| Dec 2004 | -63.85 K%(+488.1%) | -64.52 K%(+22.8%) |
| Sep 2004 | - | -52.54 K%(+107.2%) |
| Jun 2004 | - | -25.36 K%(-83.4%) |
| Mar 2004 | - | -152.37 K%(+619.7%) |
| Dec 2003 | -10.86 K%(-83.3%) | -21.17 K%(+288.8%) |
| Sep 2003 | - | -5445.21%(-39.9%) |
| Jun 2003 | - | -9061.02%(-69.3%) |
| Mar 2003 | - | -29.56 K% |
| Dec 2001 | -65.04 K%(+392.5%) | - |
| Dec 2000 | -13.21 K%(<-9900.0%) | - |
| Jan 1994 | 2.67%(+66.9%) | - |
| Jan 1993 | 1.60% | - |
FAQ
- What is Cyclacel Pharmaceuticals annual net profit margin?
- What is the all time high annual net margin for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals quarterly net profit margin?
- What is the all time high quarterly net margin for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals quarterly net margin year-on-year change?
What is Cyclacel Pharmaceuticals annual net profit margin?
The current annual net margin of CYCC is -5370.24%
What is the all time high annual net margin for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high annual net profit margin is 2.67%
What is Cyclacel Pharmaceuticals quarterly net profit margin?
The current quarterly net margin of CYCC is -19.57 K%
What is the all time high quarterly net margin for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high quarterly net profit margin is -378.88%
What is Cyclacel Pharmaceuticals quarterly net margin year-on-year change?
Over the past year, CYCC quarterly net profit margin has changed by -2566.77% (-15.10%)